Renzoku Biologics Inc. is a CDMO that leverages continuous production technology
to deliver cutting-edge biopharmaceutical manufacturing.
From research and development to cGMP manufacturing,
we support the future of healthcare with proven technology and flexible solutions.
Renzoku Biologics Inc. was established in 2023 as a CDMO for next-generation biopharmaceuticals.
We are constantly evolving to become a CDMO that meets the needs of pharmaceutical companies in both the domestic and global markets through innovative manufacturing technologies, including continuous production.
Renzoku Biologics provides comprehensive support for every stage of the process, from cell line development and process design to cGMP manufacturing and regulatory compliance. By implementing continuous production technologies that accommodate small-batch, high-variety production and real-time quality control, we achieve an optimal balance of speed, quality, and cost.
Cell Line Construction and Evaluation
Process Development and Scale-up
Technology Transfer
cGMP Manufacturing
(investigational new drug, Commercial drug)
CMC Regulatory Support
We are looking for colleagues who are committed to taking on new challenges with cutting-edge technology and passion.
We welcome applications from those eager to grow and create new value in the biopharmaceutical field.
Contact us with any questions about our services, requests for advice, or quotation requests.
